Tolemy Bio

Summary active Updated May 12, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Cambridge, United Kingdom
Founded 2024
Latest Stage Pre-Seed
Total Raised €1.4M
Website https://tolemy.bio/
Sector
biotech ai cell-therapy gene-therapy life-sciences drug-discovery

Founders

Alex Ward Co-Founder
Caelan Anderson Co-Founder

About

Tolemy Bio is a biotech startup with offices in Cambridge, UK and Barcelona, Spain, founded in 2024 by Alex Ward and Caelan Anderson, building Orbit — an AI-native virtual-cell intelligence platform that combines experimental data, agentic AI, and virtual-cell models to help advanced therapy and biologics teams make cell biology more predictable, interpretable and controllable 12. The €1.4M Pre-Seed announced May 12, 2026 was led by Norrsken Evolve with participation from Big Sur Ventures, JME Ventures, Masia, and a new UK stealth fund; capital will fund data generation, ML and engineering hiring, and early customer deployments 12.

Funding History

Date Round Amount Lead Co-investors
2026-05-12 Pre-Seed €1.4M Norrsken Evolve Big Sur Ventures, JME Ventures, Masia 12

What Investors Say

No independently sourced investor quotes found at this time.

What Founders Say

No independently sourced founder quotes found at this time.

Sources

  1. FinSMEs, “Tolemy Bio Raises €1.4M in Pre-Seed Funding,” May 12, 2026. Accessed May 2026. https://www.finsmes.com/2026/05/tolemy-bio-raises-e1-4m-in-pre-seed-funding.html↩↩↩

  2. Tech Funding News, “Pitch deck: Tolemy Bio raises €1.4M from Norrsken Evolve to build the ‘Google Maps for cells,’” May 12, 2026. Accessed May 2026. https://techfundingnews.com/pitch-deck-tolemy-bio-raises-e1-4m-from-norrsken-evolve-to-build-the-google-maps-for-cells/↩↩↩